The impact of homologous recombination deficiency on the prognosis of epithelial ovarian cancer
Clinical and Translational Medicine · 2025-01 · 15 (1)
DOI: 10.1002/ctm2.70143 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Medicine, online erschienen am 26.12.2024. Verfasst von Haiqi Su und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Beijing, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: State Key Laboratory for Complex, Severe and Rare Diseases in Peking Union Medical College Hospital, Key Research Project of Beijing Natural Science Foundation, National High Level Hospital Clinical Research Funding.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Beijing, China.
- National Clinical Research Center for Obstetric & Gynecologic Diseases, Beijing, China.
- State Key Laboratory for Complex, Severe and Rare Diseases, Peking Union Medical College Hospital, Beijing, China.
- Department of Obstetrics and Gynecology, Peking University Shenzhen Hospital, 1120 Lianhua Road, Shenzhen, China.
- School of Medicine, Southern University of Science and Technology, 1088 Xueyuan Avenue, Shenzhen, China.
- Department of Pathology, Peking Union Medical College Hospital, Beijing, China.
ORCID-Profile: Lei Li
Förderung
- State Key Laboratory for Complex, Severe and Rare Diseases in Peking Union Medical College Hospital
- Key Research Project of Beijing Natural Science Foundation
- National High Level Hospital Clinical Research Funding
- China Postdoctoral Science Foundation
Zitieren
APA
Su, H., Wang, Y., Chao, X., Wu, H., You, Y., Zhao, S., Wang, F., Sun, B., Zhang, Z., Wu, M., Zhao, Z., & Li, L. (2025). The impact of homologous recombination deficiency on the prognosis of epithelial ovarian cancer. Clinical and Translational Medicine, 15(1). https://doi.org/10.1002/ctm2.70143
Vancouver
Su H, Wang Y, Chao X, Wu H, You Y, Zhao S, et al. The impact of homologous recombination deficiency on the prognosis of epithelial ovarian cancer. Clinical and Translational Medicine. 2025;15(1). doi:10.1002/ctm2.70143
BibTeX
@article{Su2025,
author = {Su, Haiqi and Wang, Yinan and Chao, Xiaopei and Wu, Huanwen and You, Yan and Zhao, Shuru and Wang, Feiyue and Sun, Bao and Zhang, Zhen and Wu, Ming and Zhao, Zicheng and Li, Lei},
title = {The impact of homologous recombination deficiency on the prognosis of epithelial ovarian cancer},
journal = {Clinical and Translational Medicine},
year = {2025},
volume = {15},
number = {1},
doi = {10.1002/ctm2.70143}
}
EUVIMED